Log inSign up
Reading a stock page
  • The tabs show the price chart, results, shareholding, events and news for this one company.
  • The Signal Score sums up trend, momentum and quality from past data. It is a description, not a forecast.
  • Every figure names its source. "Official" means it came from NSE or BSE filings.
  • Use the star to watch the stock, or Add to portfolio to record a trade.

Prices during market hours are delayed by up to 15 minutes. Nothing here is a recommendation to buy or sell.

« Dashboard

VIVIMEDLAB ☆ BSE also on NSE

VIVIMED LABS LTD. · code 532660 · INE526G01021 · Pharma & Healthcare · series Z · Daily price history

5.50 +0.00 (+0.00%) close on 17 Nov 2026
Official NSE & BSE Auto-Sync: Checking Overview, Financials, Technicals, Shareholding & Events in the background...
26

ISA Signal Score: Poor

Avoid: price and data look unhealthy. Based on prices to 2026-11-17. Confidence 80%.

Trend10
Momentum43
52-week range3
Volume18
Risk48

Working for it

  • 50-day average is rising

Working against it

  • Price is below its 20-day average
  • Price is below its 50-day average
  • Price is below its 200-day average (long-term weakness)
  • 50-day average is below the 200-day average
  • 79% below its 52-week high
  • More volume on down days than up days (distribution)

Red flags

  • Established long-term downtrend
  • Down 79% from its 52-week high and still weakening
  • Thinly traded: average daily turnover is low, so entering or exiting can be hard

Measured reference levels (not forecasts): 20-day low 5.40, 52-week high 26.51, typical daily move 0.13, two typical moves below price 5.25.

A rule-based reading of price, volume and filed numbers. It is information, not investment advice, and it can be wrong. Do your own research.

At a glance

Five quick readings from results and prices. A starting point for your own research, not advice.
QualityNot knownNeeds the yearly results. They load from NSE on their own for NSE stocks.
GrowthNot knownNeeds the yearly results.
ValuationNot knownNeeds EPS from the yearly results.
MomentumMixedBelow its 200-day average, beat NIFTY 50 by 14.7 points
RiskHighSwings 482% a year, fell up to 81% from a peak, beta 0.51

Smart Investor Tips: VIVIMEDLAB

Caution Warranted (Trend or Balance-Sheet Headwinds)

Actionable Insights & Positives

  • Tip: Click the star button above to add this stock to your Watchlist and set a target "Buy below" alert price.

Risk Checks & Things to Verify

  • Long-term downtrend: price is below its 200-day average (Rs 6.47). Wait for a base formation and reclaim of the 50-day average (Rs 6.15) before committing fresh capital.
  • Deep drawdown (-80.4% from 52-week high). Verify earnings trend and balance-sheet debt before treating a low price as a bargain.
  • High 30-day annualized volatility (44%). Keep initial position sizes smaller and use wider stop-review levels.

BSE Authentic Bhavcopy & Cross-Exchange Check No API Key

Runs authentic BSE price & volume verification (latest BSE Bhavcopy snapshot, split-adjusted 52W High/Low, 20/50/200 DMA alignment, and 20-day volume trend, plus cross-listed NSE MCP check when shared by ISIN).

Algorithmic Momentum Prediction & Optimal Entry PriceWEAK / REDUCE ON BOUNCES (Score 26/100)

Weak trend, debt overhang, or distribution. Avoid fresh buying until price reclaims 50-DMA (Rs 6.15). If already held, protect capital if it breaks below Rs 4.86 or trim near resistance Rs 7.27.

Optimal Support areaTranche 1 (50%)Tranche 2 (50%)Risk level / ReviewLevel 1 (Swing)Level 2 (Breakout)Risk : Reward
Rs 5.06 – Rs 5.50
Ideal ~Rs 5.28
Rs 5.50 Rs 5.06 Rs 4.86
ATR 2.5%
Rs 7.27 Rs 27.99 1 : 4.7
RSI 7 · Vol 0.53x
1M 3M 6M 1Y 3Y ALL Investment checklist Download CSV 1M change -13.4% · high 6.39 · low 5.34 · max drawdown -15.0%

Live Candlestick & TradingView Chart (VIVIMEDLAB)

MARKET CLOSED - EOD SNAPSHOT
Style:  Timeframe:  Overlays:

Key figures

P/E-price / earnings
P/B-price / book value
EPS-earnings per share
Dividend yield-from saved dividend events
Debt to equity-borrowings / equity
Sales growth-yearly, needs 2+ years
Profit growth-yearly, needs 2+ years
Operating margin-EBITDA / sales

Yearly results have not loaded yet. They are read from the official NSE results filings on their own; open this page again in a minute.

About VIVIMED LABS

No company description saved yet. Use Profile below to read about this company.

Listed on BSE NSE

Market capNot available
First listed17 Aug 2005BSE not available · NSE 17 Aug 2005
Face valueRs 2
Book valueNot available
ROENot availableReturn on equity
ROCENot availableReturn on capital employed

NSE: listing date, face value

Profile completeness2 of 8Missing: description, industry, share count, book value, ROE, ROCE

Not checked yet.

Profile, History and Financial records open a web search for this company in a new tab.

Shareholding

Promoters and group 7.57% -0.20 pp, public 92.43%, as on 31 Mar 2026. Holder names and history

Day range5.50 to 5.50Open 5.50
52-week high27.99 -80.4% from high (18 Dec 2025)
52-week low4.76 +15.5% from low (11 Aug 2026)
Volume2 0.0x the 20-day average
RSI (14)37 neutral
Volatility (30d)43.5%annualised
4.76
27.99

Returns

1W-1.8%
1M-15.0%
3M+1.9%
6M-16.9%
1Y+12.2%
YTD-68.8%
3Y a year+3.9%

Against the NIFTY 50

PeriodVIVIMEDLABNIFTY 50Difference
1M-15.0%+9.7% -24.7 pts
3M+1.9%+5.1% -3.3 pts
6M-16.9%+7.5% -24.4 pts
1Y+12.2%-2.4% +14.7 pts

Risk over the past year

Volatility482%high
Deepest fall-81.4%from a peak
Beta0.51moves less than the index
Best day+441.0%18 Dec 2025
Worst day-10.0%02 Jan 2026
Up days36%of sessions

Returns use closing prices. Bonus issues and splits are adjusted automatically when detected. Beta compares daily moves with the NIFTY 50 over 213 shared sessions.

AI analysis

Company turnover, products, risks and entry ideas, written by the AI provider you set up in Settings.

Open AI analysis

Quarterly Results (Last 8 Quarters — QoQ & YoY Acceleration) Rs crore

Rs crore Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Sales / Revenue 24.622.234.226.021.021.016.012.0
Sales QoQ % -32.3%-10.1%+54.5%-24.0%-19.2%+0.0%-23.8%-25.0%
Operating Profit -4.02-0.79-0.17-1.001.000-11.0-140
Operating Margin (OPM %) -16.3%-3.6%-0.5%-3.8%4.8%0.0%-68.8%-1,166.7%
Net Profit (PAT) -8.06-4.99-6.97-6.00-5.00-7.00-17.0-147
Profit QoQ % -246.3%+38.1%-39.7%+13.9%+16.7%-40.0%-142.9%-764.7%
Profit YoY % +49.6%+75.1%+56.9%-208.9%+38.0%-40.3%-143.9%-2350.0%
Net Margin % -32.7%-22.5%-20.4%-23.1%-23.8%-33.3%-106.3%-1,225.0%

Financials

Yearly results have not loaded yet.

They are read from the official NSE results filings (XBRL) on their own when this page opens: the newest year first, then up to 5 years over the next visits. If NSE cannot be reached from your host, the line under the company facts says so.

Compared with its sector Pharma & Healthcare

StockPriceDay1 yearMkt cap (Cr)P/EP/BROENet margin
LAURUSLABSLaurus Labs Limited 2,295.00 -0.3% - 123,689 139.4 23.3 16.8% 13.1%
ZYDUSLIFEZydus Lifesciences Limited 1,195.05 -0.4% - 120,222 31.3 6.1 0.6% 0.6%
GLENMARKGLENMARK PHARMACEUTICALS LTD. 2,648.00 +1.0% - 74,724 - 9.5 -19.1% -12.7%
FORTISFORTIS HEALTHCARE LTD. 825.00 +2.0% - 62,284 59.8 - 7.8% 11.7%
GLANDGland Pharma Limited 3,331.35 +1.2% - 54,871 53.4 - 8.9% 16.0%
GLAXOGLAXOSMITHKLINE PHARMACEUTICAL 2,732.50 +0.7% - 46,291 78.5 26.0 33.2% 17.1%
EMCUREEmcure Pharmaceuticals Limited 2,336.05 -0.4% - 44,317 47.9 9.0 19.0% 10.2%
SAILIFESai Life Sciences Limited 1,800.35 +0.7% - 38,243 109.2 15.4 14.0% 15.9%
WOCKPHARMAWOCKHARDT LTD. 2,183.10 -0.2% - 33,620 166.4 6.8 4.3% 6.4%
GRANULESGRANULES INDIA LTD. 823.70 +2.4% - 19,964 34.3 3.9 11.7% 11.1%
ERISEris Lifesciences Limited 1,319.50 -0.6% - 17,949 45.8 6.9 15.2% 19.5%
ALIVUSALIVUS LIFE SCIENCES LIMITED 1,434.15 -1.1% - 17,576 37.3 7.5 20.2% 20.6%
Sector median- 53.09.012.8%

The 12 largest of 80 stocks in this sector on BSE, by market cap where known and traded value otherwise. Valuation shows for stocks whose results this site has read; it fills in as people open more stock pages. Prices from 20 Nov 2026.

Today: 15 minute chart and signal

Opens when you view this tab.

Analysis and next-session reading

Opens when you view this tab.

Complete analysis report Financials, shareholding, events, risks and a data reliability score.

Signals

Price is below its 50-day average 20-day average is above the 50-day (short-term uptrend) Price is below its 200-day average (long-term downtrend) RSI 37: neutral

Simple rules applied to end-of-day prices. They describe what the chart is doing and are not advice to buy or sell.

When is a good price? from this stock's own price history

The price is in the lower quarter of its 1-year range and is lower than it was on 82% of days in the past year.

Support (prices below today's)

20-day low5.34-2.9%
60-day low4.76-13.5%
52-week low4.76-13.5%

Resistance (prices above today's)

50-day average6.15+11.8%
200-day average6.47+17.6%
20-day high7.27+32.2%
60-day high7.27+32.2%

Zones buyers often watch

Lower quarter of the 1-year range 4.76 to 10.57 price is inside this zone now
Pullback of 10% to 20% from the high 22.39 to 25.19 A common area for dips inside an uptrend.
Around the 200-day average 6.27 to 6.66 Long-term trend line, often watched as support.

Deepest fall from a peak in the past year: -81.4%. Currently -79.3% below its latest peak. Levels are from history and do not predict where the price will go.

Moving averages and momentum

IndicatorValueReading
20-day average6.17 Price is 10.9% below
50-day average6.15 Price is 10.6% below
200-day average6.47 Price is 14.9% below
RSI (14)37Neutral
MACD (12, 26, 9)-0.18Below its signal line (momentum fading)
Volatility (30d)43.5%Medium yearly swings

Support and resistance

R25.50
R15.50
Pivot5.50
S15.50
S25.50

Classic pivot levels from the latest session's high, low and close. Prices often pause near them, but they are only reference points.

DateOpenHighLow CloseChangeVolume
2026-11-17 5.50 5.50 5.50 5.50 +0.00% 2
2026-11-16 5.40 5.50 5.40 5.50 +1.85% 50,000
2026-11-13 5.34 5.40 5.34 5.40 -0.74% 24,148
2026-11-12 5.44 5.44 5.44 5.44 -1.98% 1
2026-11-11 5.49 5.55 5.49 5.55 -0.89% 6,050
2026-11-09 5.60 5.60 5.60 5.60 -1.93% 1,000
2026-11-05 5.77 5.82 5.77 5.82 -1.02% 2,181
2026-11-04 5.88 5.88 5.88 5.88 -1.84% 6,009
2026-11-02 5.99 5.99 5.99 5.99 -1.96% 50
2026-10-23 6.11 6.11 6.11 6.11 -1.93% 2,655
2026-10-21 6.39 6.39 6.23 6.23 -1.89% 12
2026-10-19 6.35 6.36 6.35 6.35 -1.85% 778

News from the last 15 days More

Shareholding pattern

OutdatedNSE listingChecks passed

Quarter ended 31 Mar 2026, filed 17 Apr 2026. Expected quarter Sep 2026 is not in the database yet. The latest filing is for Mar 2026. Company: Vivimed Labs Limited, ISIN INE526G01021.

Promoters and group
7.57%
-0.20 pp vs Dec 2025
Public (all, Category B)
92.43%
+0.20 pp vs Dec 2025

Foreign, domestic institution and mutual fund lines need the filing file for the period. An admin can load them under Admin > Shareholding tracker.

Ownership split

Trend

Latest quarter compared

CategoryPrevious (Dec 25)Latest (Mar 26)Change (pp)Change in sharesYear earlier (pp)What it may mean
Promoters and group7.77%7.57%-0.20 pp--13.37 ppPromoter holding fell. A change alone is not a sell or buy signal. Check the filing for the reason (market sale, transfer inside the group, new issue).
Public (all, Category B)92.23%92.43%+0.20 pp-+13.37 ppPublic holding rose. This is the mirror of promoter and other changes. It does not show what retail investors did.

Change is in percentage points (latest percent minus previous percent), not a relative change. Mutual funds and insurers are part of domestic institutions and are never added to it. Only comparable quarters (1 to 6 months apart; about a year for the year-earlier column) are compared.

Insights and risk alerts

Low Latest filing is older than expected Mar 2026

The newest filing here is for Mar 2026.

Rule: Rule F1: the filing window for the quarter ended 30 Sep 2026 has closed and no filing for it is in the database.

Limits: The company may have filed and not yet been imported, or may be late.

Check next: Check the exchange filings page, then import the new listing.

These alerts describe reported ownership. They are not buy or sell advice. Judge the company with its results, debt, valuation and announcements.

Who holds the shares

Largest holders named in the Mar 2026 filing.

NameTypeShares% of companyLocked-in shares
Kitara Piin 1102Foreign Companies77,66,3879.37% -
Varalwar SandeepIndividuals Or HUF23,27,6322.81% -
William F HarveyForeign Nationals13,69,8401.65% -
Sameer Mahendra SampatNon Resident Indians13,59,1651.64% -
Subhash VaralwarIndividuals Or HUF13,49,1541.63% -
Amicorp Capital (Mauritius) LimitedInstitutions Foreign Portfolio Investor One12,19,2981.47% -

Quarter by quarter

Quarter endedPromotersChangePublicChangeFiledSource
Mar 20267.57%-0.20 pp92.43%+0.20 pp17 Apr 2026
Dec 2025 revised7.77%0.00 pp92.23%0.00 pp09 Jan 2026
Sep 20257.77%0.00 pp92.23%0.00 pp14 Oct 2025
Jun 20257.77%-13.17 pp92.23%+13.17 pp10 Sep 2025
Mar 202520.94%0.00 pp79.06%0.00 pp14 Apr 2025NSE
Dec 202420.94%0.00 pp79.06%0.00 pp16 Jan 2025NSE
Sep 202420.94%0.00 pp79.06%0.00 pp17 Oct 2024NSE
Jun 202420.94%0.00 pp79.06%0.00 pp18 Jul 2024NSE
Mar 202420.94%0.00 pp79.06%0.00 pp27 Apr 2024NSE
Dec 202320.94%0.00 pp79.06%0.00 pp09 Jan 2024NSE
Sep 202320.94%0.00 pp79.06%0.00 pp20 Oct 2023NSE
Jun 202320.94%0.00 pp79.06%0.00 pp20 Jul 2023NSE
Mar 202320.94%-0.02 pp79.06%+0.02 pp18 Apr 2023NSE
Dec 202220.96%0.00 pp79.04%0.00 pp18 Jan 2023NSE
Sep 202220.96%0.00 pp79.04%0.00 pp17 Oct 2022NSE
Jun 202220.96%-1.02 pp79.04%+1.02 pp20 Jul 2022NSE
Mar 202221.98%-6.59 pp78.02%+6.59 pp19 Apr 2022NSE
Dec 2021 revised28.57%0.00 pp71.43%0.00 pp11 Jan 2022NSE
Sep 202128.57%0.00 pp71.43%0.00 pp13 Oct 2021NSE
Jun 2021 revised28.57%-71.43%-20 Jul 2021NSE
Shareholding details

Loading...

Events

Not checked yet

BSE events come from the BSE corporate actions file, which an admin uploads. There is no automatic BSE fetch. Nothing has been imported for this stock yet.

No events saved for this stock yet.

Fetched from NSE automatically and saved on this site, so past events stay available. Ex date is the first day the stock trades without the benefit; a bonus or split is applied to old prices on its own from that day. Confirm on the exchange website before acting.

ISA shows information and signals worked out from past prices and company filings. They are not recommendations to buy, sell or hold any security, and ISA is not a SEBI-registered investment adviser or research analyst. Prices may be delayed. Check with a registered adviser before you invest.